Clinical Outcomes in Adolescents and Adults After the Fontan Procedure |
| |
Authors: | Mark Dennis Diana Zannino Karin du Plessis Andrew Bullock Patrick J.S. Disney Dorothy J. Radford Tim Hornung Leeanne Grigg Rachael Cordina Yves d’Udekem David S. Celermajer |
| |
Affiliation: | 1. Sydney Medical School, University of Sydney, Camperdown, Sydney, Australia;2. Department of Cardiology, Royal Prince Alfred Hospital, Missenden Road, Sydney, Australia;3. Murdoch Children’s Research Institute, Melbourne, Australia;4. Children’s Cardiac Centre, Princess Margaret Hospital for Children, Perth, Australia;5. Department of Cardiovascular Services, Royal Adelaide Hospital, Adelaide, Australia;6. Adult Congenital Heart Unit, The Prince Charles Hospital, Brisbane, Australia;g. Green Lane Paediatric and Congenital Cardiac Service, Starship Children’s Hospital Auckland, Auckland, New Zealand;h. Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Australia;i. Departments of Cardiac Surgery and Cardiology, Royal Children’s Hospital, Melbourne, Australia |
| |
Abstract: | BackgroundLong-term outcomes of Fontan patients who survive to age ≥16 years have not been well characterized. The Australian and New Zealand Fontan Registry (ANZFR) provides a unique opportunity to understand survival and complication rates in Fontan patients who transition to adult congenital heart disease centers.ObjectivesThis study sought to describe the survival and complications of adult patients who have had a Fontan procedure.MethodsThe study analyzed outcomes in patients ≥16 years of age who were prospectively enrolled in the ANZFR.ResultsData from all 683 adult survivors from the ANZFR were analyzed. Mortality status was confirmed from the National Death Index. There were 201 atriopulmonary (AP) connections and 482 total cavopulmonary connections (249 lateral tunnels and 233 extracardiac conduits). For these subjects, the survival rate at age 30 years was 90% (95% CI: 87% to 93%), and it was 80% (95% CI: 75% to 87%) at 40 years of age. Survival at age 30 years was significantly worse for the patients with AP connections (p = 0.03). At latest follow-up, only 53% of patients were in New York Heart Association functional class I. After the age of 16 years, 136 (20%) had experienced at least 1 new arrhythmia, 42 (6%) required a permanent pacemaker, 45 (7%) had a thromboembolic event, and 135 (21%) required a surgical reintervention. Only 41% (95% CI: 33% to 51%) of Fontan patients were free of serious adverse events at 40 years of age.ConclusionsThis comprehensively followed cohort showed that a variety of morbid complications is common in Fontan adults, and that there is a substantial incidence of premature death, particularly in patients with AP connections. |
| |
Keywords: | adult congenital heart disease arrhythmia Fontan single ventricle ACHD adult congenital heart disease ANZFR Australian and New Zealand Fontan Registry AP atriopulmonary AV atrioventricular ECC extracardiac conduit LT lateral tunnel PLE protein-losing enteropathy SVT supraventricular tachycardia TCPC total cavopulmonary connection |
本文献已被 ScienceDirect 等数据库收录! |
|